1. Home
  2. Live Updates
  3. Michael strapazon

Live Breaking News & Updates on Michael strapazon

Stay informed with the latest breaking news from Michael strapazon on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Michael strapazon and stay connected to the pulse of your community

GLOBAL BIOTECHNOLOGY LEADER AMGEN BREAKS GROUND ON NEW MANUFACTURING FACILITY IN NORTH CAROLINA

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the groundbreaking of its newest biomanufacturing facility, located in Holly Springs, North Carolina. The...

Puerto-rico , United-states , North-carolina , Netherlands , Thousand-oaks , California , Singapore , Rhode-island , Ohio , Ireland , Holly-springs , Americans

AMGEN TO PRESENT AT THE 42ND ANNUAL COWEN HEALTHCARE CONFERENCE

/PRNewswire/ -- Amgen (NASDAQ:AMGN) will virtually present at the 42nd Annual Cowen Healthcare Conference at 11:10 a.m. ET on Tuesday, March 8, 2022. Murdo...

Michael-strapazon , Megan-fox , Peterh-griffith , Murdo-gordon , Amgen , Annual-cowen-healthcare-conference , Global-commercial-operations , Investor-relations-events , Dow-jones-industrial-average , Best-workplaces , Great-place , Thousand-oaks

AMGEN TO PRESENT AT THE 42ND ANNUAL COWEN HEALTHCARE CONFERENCE

/PRNewswire/ -- Amgen (NASDAQ:AMGN) will virtually present at the 42nd Annual Cowen Healthcare Conference at 11:10 a.m. ET on Tuesday, March 8, 2022. Murdo...

Michael-strapazon , Megan-fox , Peterh-griffith , Murdo-gordon , Amgen , Annual-cowen-healthcare-conference , Global-commercial-operations , Investor-relations-events , Dow-jones-industrial-average , Best-workplaces , Great-place , Thousand-oaks

NEW DATA FURTHER REINFORCE EFFICACY OF TEZSPIRE™ (TEZEPELUMAB-EKKO) IN A BROAD POPULATION OF SEVERE ASTHMA PATIENTS

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United-states , Puerto-rico , America , Michael-strapazon , Megan-fox , Kyowa-kirin-co-ltd , Amgen , Beigene-ltd , Clinical-trial-program , Exchange-commission , Astrazeneca , Therapeutics-inc

NEW DATA FURTHER REINFORCE EFFICACY OF TEZSPIRE™ (TEZEPELUMAB-EKKO) IN A BROAD POPULATION OF SEVERE ASTHMA PATIENTS

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced results from a pooled post-hoc analysis of the pivotal NAVIGATOR Phase 3 and PATHWAY Phase 2b trials showed...

Puerto-rico , United-states , America , Lymphopoietin-isoforms , Michael-strapazon , Megan-fox , Kyowa-kirin-co-ltd , Centers-for-disease , Amgen , Beigene-ltd , Exchange-commission , World-allergy-organization

NEW DATA FURTHER REINFORCE EFFICACY OF TEZSPIRE™ (TEZEPELUMAB-EKKO) IN A BROAD POPULATION OF SEVERE ASTHMA PATIENTS

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced results from a pooled post-hoc analysis of the pivotal NAVIGATOR Phase 3 and PATHWAY Phase 2b trials showed...

Puerto-rico , United-states , America , Lymphopoietin-isoforms , Michael-strapazon , Megan-fox , Kyowa-kirin-co-ltd , Centers-for-disease , Amgen , Beigene-ltd , Exchange-commission , World-allergy-organization

LUMAKRAS® (SOTORASIB) SHOWS ENCOURAGING AND CLINICALLY MEANINGFUL ANTICANCER ACTIVITY IN PATIENTS WITH KRAS G12C-MUTATED ADVANCED PANCREATIC CANCER IN CODEBREAK 100 TRIAL

/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the presentation of efficacy and safety data from the CodeBreaK 100 Phase 1/2 trial in patients with KRAS...

United-states , United-kingdom , Qatar , Australia , Taiwan , Japan , Hong-kong , Argentina , Brazil , Colombia , United-arab-emirates , Canada

LUMAKRAS® (SOTORASIB) SHOWS ENCOURAGING AND CLINICALLY MEANINGFUL ANTICANCER ACTIVITY IN PATIENTS WITH KRAS G12C-MUTATED ADVANCED PANCREATIC CANCER IN CODEBREAK 100 TRIAL

/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the presentation of efficacy and safety data from the CodeBreaK 100 Phase 1/2 trial in patients with KRAS...

United-states , United-kingdom , Qatar , Australia , Taiwan , Japan , Hong-kong , Argentina , Brazil , Colombia , United-arab-emirates , Canada

AMGEN PROVIDES LONG-TERM GUIDANCE THROUGH 2030 DURING BUSINESS REVIEW MEETING

/PRNewswire/ -- In connection with its virtual business review, Amgen (NASDAQ:AMGN) provided preliminary long-term guidance between 2022 and 2030 in addition...

Puerto-rico , Michael-strapazon , Megan-fox , Kyowa-kirin-co-ltd , Amgen , Plexium-inc , Beigene-ltd , Exchange-commission , Biomedicines-inc , Therapeutics-inc , Amgen-inc , Arrakis-therapeutics-inc

AMGEN OUTLINES GROWTH STRATEGY THROUGH 2030 AT VIRTUAL BUSINESS REVIEW

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today outlined its growth strategy through 2030, a period during which the Company expects to deliver attractive financial...

Rhode-island , United-states , United-kingdom , China , Puerto-rico , Japan , North-carolina , Ohio , Canada , Susan-sweeney , Ray-deshaies , David-reese